European Prenatal Genetic Testing Market Revitalised by Advancements in NGS and NIPT Technologies

Jan 23, 2018

Frost & Sullivan’s latest analysis of the European prenatal genetic testing market point to advancements in technologies, such as next-generation sequencing techniques (NGS) and use of non-invasive prenatal testing (NIPT), as the key factors triggering market growth. The new research, Growth Opportunities in European Prenatal Genetic Testing Market, Forecast to 2021, projects that the market will reach $615.7 million by 2021 at a compound annual growth rate (CAGR) of 9.6 percent. Frost & Sullivan expects the transitioning to NGS, implementation of cloud computing platforms, application of Big Data for in-house data interpretation and collaborative business models to open new growth ...

Read More

Almac Group announces further expansion in support of clinical and commercial drug supplies at its European Campus in Dundalk, Ireland following successful HPRA Inspections

Jan 19, 2018

Almac Group, the global contract pharmaceutical development and manufacturing organisation, today confirmed the successful completion of Health Products Regulatory Authority (HPRA) inspections of Almac Clinical Services Ireland and Almac Pharma Services Ireland at its European campus in Dundalk, Ireland. Almac previously confirmed that it secured new premises in Dundalk, Ireland in January 2017 as part of its ongoing global expansion strategy, to meet client demand and to address any potential challenges that may arise due to Brexit. Following these successful HPRA inspections, Almac Group look forward to being officially licensed to conduct QP batch certification and release for both clinical ...

Read More

Sharp completes first phase of $23 million investment in its Bethlehem clinical services facility

Jan 9, 2018

Sharp – a part of UDG Healthcare plc, a global leader in contract packaging and clinical supply services, has completed the first phase in the development of its new USD $23m state-of-the-art facility in Bethlehem, PA. Sharp acquired the new Bethlehem facility for $14m in 2017 and has now completed a $2.5m relocation project, transferring the company’s clinical storage and distribution services from its Phoenixville site. A second phase will see Sharp co-locate its fully integrated clinical services offering at the site when its packaging, manufacturing and analytical services move to the facility in late-2018, following a $6.4 million refit. ...

Read More

What Clinical Teams Should Know about Changing Trial Logistics and How they will Affect Development – PART 2

Jan 4, 2018

As we shift to what has been described as “an Amazonlike culture”, sponsors want the same opportunity to track shipments in real time and to obtain real-time data that they can analyse. In her paper, Jennifer Worsfold, of Fisher Clinical Services, explains that this has led to a growing focus on new technology, including downloadable temperature monitors, and the ability to access real-time updates on the location and temperature condition of supply shipments. ...

Read More

ProImmune introduces MutaMap high-throughput service for mutational activity maps of therapeutic proteins

Dec 12, 2017

ProImmune, a leader in services for understanding immune responses, has announced the introduction of MutaMap™, a new high-throughput assay service for understanding the impact of point mutations on protein therapeutic activity, including monoclonal antibodies. MutaMap provides a high-throughput service, with high-quality output data, to help decide which individual point mutations to pursue and enable better protein engineering decisions to be made, prior to committing a drug candidate to a clinical program. MutaMap is an in vitro assay system that explores the effect of deliberate point mutations on protein activity by substituting each of the 19 possible amino acid alternatives in ...

Read More